Canopy Growth Corporation will release its financial results for the third quarter fiscal year 2022 ended December 31, 2021 before financial markets open on February 9, 2022. Following the release of its third quarter fiscal year 2022 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, Interim CFO at 10:00 AM Eastern Time on February 9, 2022.
Webcast Information
A live audio webcast will be available at:
https://produceredition.webcasts.com/starthere.jsp?ei=1522299&tp_key=2532dadd5d
Replay Information
A replay will be accessible by webcast until 11:59 PM ET on May 10, 2022 at:
https://produceredition.webcasts.com/starthere.jsp?ei=1522299&tp_key=2532dadd5d
About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. For more information visit www.canopygrowth.com.
